Roberto Chiarle
Associate Professor of Pathology, Harvard Medical School · Mass General Brigham
Credentials: · ·
History
- Present
- 1997–1998
New York University Medical Center
- 1993–1997
Pathology-Anatomic and Clinical
- 1989–1993
University of Torino Medical School, Italy
Research
The anaplastic lymphoma kinase in the pathogenesis of cancer
Review · Nature reviews. Cancer · 2008 · First of 5 authors · Corresponding · 698 citations
Cell · 2011 · First of 15 authors · 385 citations
Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target
Nature Medicine · 2005 · First of 9 authors · 376 citations
- GI
35 papers
- MA
6 papers
- AG
4 papers
4 papers
- AP
3 papers
3 papers · 3 as a resident
- CV
3 papers · 1 as a resident
3 papers
Grants
- 2015–2026
Mechanisms of Resistance to ALK Inhibitors in ALK-Rearranged Lymphoma
National Cancer Institute · R01
Contact PI · $4.1M · Boston Children's Hospital
- 2017–2023
APOBEC Proteins as Drivers of Chromosomal Translocations in Solid Cancers
National Cancer Institute · R01
Contact PI · $2M · Boston Children's Hospital